Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1991 Nov 2;303(6810):1093–1096. doi: 10.1136/bmj.303.6810.1093

Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.

C A Lee 1, A N Phillips 1, J Elford 1, G Janossy 1, P Griffiths 1, P Kernoff 1
PMCID: PMC1671314  PMID: 1781870

Abstract

OBJECTIVE--To describe the progression of HIV disease in a haemophilic cohort and to show the influence of treatment. DESIGN--11 year longitudinal clinical and laboratory study. SETTING--A haemophilia centre. PATIENTS--111 patients infected with HIV during October 1979 to July 1985. MAIN OUTCOME MEASURES--Symptoms of HIV infection, AIDs, and death. INTERVENTIONS--26 asymptomatic patients started taking zidovudine or placebo (1000 mg/day) during November 1988 to February 1990; 10 patients with CD4+ counts of 0.2 x 10(9)/l started zidovudine 500 mg/day during January to November 1990. 35 patients used pentamidine for primary or secondary prophylaxis. RESULTS--At 11 years from seroconversion the estimated rate of progression to AIDS was 42% (95% confidence interval 27% to 57%); to symptoms 85% (75% to 95%); and to death 41% (25% to 57%). Progression to AIDS was significantly faster in patients aged 25 and over than in those aged less than 25 (relative risk 5.0 (2.4 to 10.4); p less than 0.00001) and in those with previous cytomegalovirus infection than in those not infected (relative risk 3.0 (1.4 to 6.8); p = 0.006). 16 of 27 (59%) patients with p24 antigenaemia developed AIDS compared with 17 of 84 (20%) patients without p24 antigen (p less than 0.001). The risk of progression to AIDS before 30 November 1988 in patients with CD4+ counts less than or equal to 0.2 x 10(9)/l was higher than after November 1988 (relative risk 1.9 (0.85 to 4.43); p = 0.1). For 1989 and 1990 the observed cumulative numbers of AIDS cases (among 81 patients with sufficient CD4+ counts) were 22 and 25 compared with 29 and 37 predicted from the rate of fall of CD4+ counts up to the end of 1988 (p = 0.03). CONCLUSION--Treatment seems to be reducing the progression of HIV disease in this haemophilic cohort.

Full text

PDF
1093

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beard J., Savidge G. F. High-dose intravenous immunoglobulin and splenectomy for the treatment of HIV-related immune thrombocytopenia in patients with severe haemophilia. Br J Haematol. 1988 Mar;68(3):303–306. doi: 10.1111/j.1365-2141.1988.tb04206.x. [DOI] [PubMed] [Google Scholar]
  2. Breslow N. E., Day N. E. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1–406. [PubMed] [Google Scholar]
  3. Cheingsong-Popov R., Panagiotidi C., Bowcock S., Aronstam A., Wadsworth J., Weber J. Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. BMJ. 1991 Jan 5;302(6767):23–26. doi: 10.1136/bmj.302.6767.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Darby S. C., Rizza C. R., Doll R., Spooner R. J., Stratton I. M., Thakrar B. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. BMJ. 1989 Apr 22;298(6680):1064–1068. doi: 10.1136/bmj.298.6680.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eyster M. E., Gail M. H., Ballard J. O., Al-Mondhiry H., Goedert J. J. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med. 1987 Jul;107(1):1–6. doi: 10.7326/0003-4819-107-1-1. [DOI] [PubMed] [Google Scholar]
  6. Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. doi: 10.1056/NEJM198707233170401. [DOI] [PubMed] [Google Scholar]
  7. Friedland G. H. Early treatment for HIV: the time has come. N Engl J Med. 1990 Apr 5;322(14):1000–1002. doi: 10.1056/NEJM199004053221409. [DOI] [PubMed] [Google Scholar]
  8. Giesecke J., Scalia-Tomba G., Berglund O., Berntorp E., Schulman S., Stigendal L. Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. BMJ. 1988 Jul 9;297(6641):99–102. doi: 10.1136/bmj.297.6641.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jackson J. B., Erice A., Englund J. A., Edson J. R., Balfour H. H., Jr Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1. Transfusion. 1988 Mar-Apr;28(2):187–189. doi: 10.1046/j.1537-2995.1988.28288179029.x. [DOI] [PubMed] [Google Scholar]
  10. Lane H. C., Masur H., Gelmann E. P., Longo D. L., Steis R. G., Chused T., Whalen G., Edgar L. C., Fauci A. S. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med. 1985 Mar;78(3):417–422. doi: 10.1016/0002-9343(85)90332-8. [DOI] [PubMed] [Google Scholar]
  11. Lee C. A., Kernoff P. B., Karayiannis P., Thomas H. C. Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophilia. Br J Haematol. 1989 Jun;72(2):235–238. doi: 10.1111/j.1365-2141.1989.tb07688.x. [DOI] [PubMed] [Google Scholar]
  12. Lee C. A., Phillips A., Elford J., Miller E. J., Bofill M., Griffiths P. D., Kernoff P. B. The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol. 1989 Oct;73(2):228–234. doi: 10.1111/j.1365-2141.1989.tb00257.x. [DOI] [PubMed] [Google Scholar]
  13. Lee C. A., Webster A., Griffiths P. D., Kernoff P. B. Symptomless HIV infection after more than ten years. Lancet. 1990 Feb 17;335(8686):425–426. doi: 10.1016/0140-6736(90)90273-8. [DOI] [PubMed] [Google Scholar]
  14. Lever A. M., Brook M. G., Yap I., Thomas H. C. Treatment of thrombocytopenia with alfa interferon. Br Med J (Clin Res Ed) 1987 Dec 12;295(6612):1519–1520. doi: 10.1136/bmj.295.6612.1519-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lim S. G., Lee C. A., Kernoff P. B. The treatment of HIV associated thrombocytopenia in haemophiliacs. Clin Lab Haematol. 1990;12(3):237–245. doi: 10.1111/j.1365-2257.1990.tb00033.x. [DOI] [PubMed] [Google Scholar]
  16. Lim S. G., Lee C. A., Kernoff P. B. Zidovudine treatment for anti-HIV positive haemophiliacs. Clin Lab Haematol. 1990;12(4):367–378. doi: 10.1111/j.1365-2257.1990.tb00348.x. [DOI] [PubMed] [Google Scholar]
  17. Medina I., Mills J., Leoung G., Hopewell P. C., Lee B., Modin G., Benowitz N., Wofsy C. B. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med. 1990 Sep 20;323(12):776–782. doi: 10.1056/NEJM199009203231202. [DOI] [PubMed] [Google Scholar]
  18. Phillips A. N., Lee C. A., Elford J., Janossy G., Timms A., Bofill M., Kernoff P. B. Serial CD4 lymphocyte counts and development of AIDS. Lancet. 1991 Feb 16;337(8738):389–392. doi: 10.1016/0140-6736(91)91166-r. [DOI] [PubMed] [Google Scholar]
  19. Phillips A., Lee C. A., Elford J., Janossy G., Bofill M., Timms A., Kernoff P. B. Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort. AIDS. 1989 Nov;3(11):737–741. doi: 10.1097/00002030-198911000-00008. [DOI] [PubMed] [Google Scholar]
  20. Pottage J. C., Jr, Benson C. A., Spear J. B., Landay A. L., Kessler H. A. Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine. JAMA. 1988 Nov 25;260(20):3045–3048. doi: 10.1001/jama.260.20.3045. [DOI] [PubMed] [Google Scholar]
  21. Proctor S. J., Jackson G., Carey P., Stark A. Short-course alpha-interferon therapy in severe unresponsive immune thrombocytopenic purpura. Lancet. 1988 Apr 23;1(8591):947–947. doi: 10.1016/s0140-6736(88)91766-7. [DOI] [PubMed] [Google Scholar]
  22. Rugman F. P., Mannion P. T., Hay C. R., Bolton-Maggs P., Roberts D., Mutton K. J. Cytomegalovirus, serum beta 2 microglobulin, and progression to AIDS in HIV-seropositive haemophiliacs. Lancet. 1989 Sep 9;2(8663):631–631. doi: 10.1016/s0140-6736(89)90762-9. [DOI] [PubMed] [Google Scholar]
  23. Rutherford G. W., Lifson A. R., Hessol N. A., Darrow W. W., O'Malley P. M., Buchbinder S. P., Barnhart J. L., Bodecker T. W., Cannon L., Doll L. S. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ. 1990 Nov 24;301(6762):1183–1188. doi: 10.1136/bmj.301.6762.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Simonds A. K., Newman S. P., Johnson M. A., Talaee N., Lee C. A., Clarke S. W. Alveolar targeting of aerosol pentamidine. Toward a rational delivery system. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):827–829. doi: 10.1164/ajrccm/141.4_Pt_1.827. [DOI] [PubMed] [Google Scholar]
  25. Simonds A. K., Newman S. P., Johnson M. A., Talaee N., Lee C. A., Clarke S. W. Simple nebuliser modification to enhance alveolar deposition of pentamidine. Lancet. 1989 Oct 21;2(8669):953–953. doi: 10.1016/s0140-6736(89)90957-4. [DOI] [PubMed] [Google Scholar]
  26. Swart A. M., Weller I., Darbyshire J. H. Early HIV infection: to treat or not to treat? BMJ. 1990 Oct 13;301(6756):825–826. doi: 10.1136/bmj.301.6756.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ward J. W., Bush T. J., Perkins H. A., Lieb L. E., Allen J. R., Goldfinger D., Samson S. M., Pepkowitz S. H., Fernando L. P., Holland P. V. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med. 1989 Oct 5;321(14):947–952. doi: 10.1056/NEJM198910053211406. [DOI] [PubMed] [Google Scholar]
  28. Webster A., Lee C. A., Cook D. G., Grundy J. E., Emery V. C., Kernoff P. B., Griffiths P. D. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet. 1989 Jul 8;2(8654):63–66. doi: 10.1016/s0140-6736(89)90312-7. [DOI] [PubMed] [Google Scholar]
  29. de Wolf F., Goudsmit J., Paul D. A., Lange J. M., Hooijkaas C., Schellekens P., Coutinho R. A., van der Noordaa J. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J (Clin Res Ed) 1987 Sep 5;295(6598):569–572. doi: 10.1136/bmj.295.6598.569. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES